Posted in | News | Nanomedicine | Nanomaterials

Researchers Develop New Nanoparticle-Based Drug Technology

For over 30 years, researchers have been trying to use magnetic nanoparticles for drugy delivery. Now, a research team headed by Dr Nial Wheate from the University of Sydney’s Faculty of Pharmacy together with partners in Scotland has developed a technique to magnetically deliver drugs using iron, gold and platinum.

The study results have been reported online in the Inorganica Chimica Acta journal. The researchers have created a novel anticancer drug consisting of an iron oxide core with a size of 5 nm. Dr Wheate informed that the researchers coated gold over this iron oxide core as a protective layer prior to affixing cisplatin, a platinum drug for testicular cancer treatment, onto the gold coating utilizing spaghetti-like polymer strings.

The key feature of this novel drug is the mobility of its iron core when a magnetic field is applied. Dr Wheate stated that drugs can be exactly directed to the targeted site utilizing strong magnetic fields. On the other hand, drugs can be drawn towards the cancer site by implanting a powerful magnet into a tumor. The team demonstrated the method in the lab by growing cancer cells in plates. When a magnet was located below the plates, the drug destroyed cells that were growing close to the magnet without harming other cells.

In chemotherapies, drugs spread across the body, thus destroying both cancer cells as well as healthy organs, which in turn results in unwanted side-effects. However, this drug technology is capable of reducing or eliminating adverse side-effects such as an elevated risk of infection, low red blood cells, vomiting, nausea, and hair loss. It also shows promise in treating cancers that are incurable with traditional platinum drugs such as prostate cancer.

Source: http://sydney.edu.au

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 12). Researchers Develop New Nanoparticle-Based Drug Technology. AZoNano. Retrieved on April 26, 2024 from https://www.azonano.com/news.aspx?newsID=24958.

  • MLA

    Thomas, G.P.. "Researchers Develop New Nanoparticle-Based Drug Technology". AZoNano. 26 April 2024. <https://www.azonano.com/news.aspx?newsID=24958>.

  • Chicago

    Thomas, G.P.. "Researchers Develop New Nanoparticle-Based Drug Technology". AZoNano. https://www.azonano.com/news.aspx?newsID=24958. (accessed April 26, 2024).

  • Harvard

    Thomas, G.P.. 2019. Researchers Develop New Nanoparticle-Based Drug Technology. AZoNano, viewed 26 April 2024, https://www.azonano.com/news.aspx?newsID=24958.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.